« Back to Record
Citation APA

Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., Schandené, L., Crenier, L., De Block, C., Seigneurin, J.-M., De Pauw, P., Pierard, D., Weets, I., Rebello, P., Bird, P., Berrie, E., Frewin, M., Waldmann, H., Bach, J.-F., Pipeleers, D., & Chatenoud, L. (2005). Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. The New England journal of medicine, 352(25), 2598-2608. doi:10.1056/NEJMoa043980


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/50930

Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., Schandené, L., Crenier, L., De Block, C., Seigneurin, J.-M., De Pauw, P., Pierard, D., Weets, I., Rebello, P., Bird, P., Berrie, E., Frewin, M., Waldmann, H., Bach, J.-F., Pipeleers, D., & Chatenoud, L. (2005). Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. The New England journal of medicine, 352(25), 2598-2608. doi:10.1056/NEJMoa043980